[The effect of mexiletine, ajmaline and aprindine on ventricular arrhythmias].
D000368:Aged; D000404:Ajmaline / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles; D006439:Hemodynamics; D006801:Humans; D007192:Indenes / Q000627:therapeutic use*; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use*; D008875:Middle Aged; D011437:Propylamines / Q000627:therapeutic use*; D013997:Time Factors
D007192:Indenes; D011437:Propylamines; D000404:Ajmaline; D008801:Mexiletine; D001073:Aprindine
Beeinflussung ventrikulärer Rhythmusstörungen durch Mexiletin, Ajmalin und Aprindin.